アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk - aripiprazole - oral solution - 1mg/1ml

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - oral solution - 20mg/1ml ; 80mg/1ml

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

otsuka pharmaceuticals (u.k. - aripiprazole - oral solution - 1mg/1ml

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - dexamethasone sodium phosphate - oral solution - 400microgram/1ml

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - aripiprazole - oral solution - 1mg/1ml

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - aripiprazole - oral solution - 1mg/1ml

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - aripiprazole - oral solution - 1 milligram(s)/millilitre - other antipsychotics; aripiprazole - other antipsychotics - aripiprazole is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. aripiprazole is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; mannitol; sucralose; carmellose calcium - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; carmellose calcium; sucralose; mannitol - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.